BUY (USCF SummerHaven SHPEI Index Fund) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

The investment seeks to track the price and yield performance, before fees and expenses, of the SummerHaven Private Equity Strategy IndexSM ("SHPEI"). Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the common stocks comprising SHPEI. It generally invests in substantially all of the common stocks comprising SHPEI and in approximately the same proportions as SHPEI. SHPEI attempts to replicate the long-term (i.e., 10 years or more) return characteristics of diversified private equity allocations.
Is BUY's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Strategy offers four perpetual preferred shares ('STRXs') targeting high-yield investors seeking Bitcoin exposure without direct crypto ownership. I rate STRF and STRD a BUY for their 10%+ yields, with STRF offering top liquidation priority and STRD higher yield but greater risk. I rate STRK a BUY for Bitcoin holders desiring income with potential equity upside through convertibility into MSTR common stock.

On the night before Thanksgiving, a popular time for young adults to reconnect with friends, Chipotle will fuel hometown reunions with an in-restaurant BUY-ONE-GET-ONE (BOGO) entrée offer on Wednesday, November 26 from 4 p.m. to close local time1 To celebrate Cyber Weekend, Chipotle is running a $0 delivery fee offer2 on orders placed through the Chipotle app and Chipotle.com from Friday, November 28 through Monday, December 1 with code CYBER25 NEWPORT BEACH, Calif.

Jazz Pharmaceuticals (JAZZ) receives a BUY rating, driven by strong DUET trial results for Xywav in narcolepsy and idiopathic hypersomnia. JAZZ's growth is anchored by Xywav and Epidiolex, both generating robust sales and supporting future oncology pipeline expansion. Recent clinical milestones, upcoming FDA decisions, and a well-executed leadership transition position JAZZ for long-term value creation.

Robinhood Markets, Inc.'s launch of presidential election event contracts and Robinhood Legend aims to attract more active traders and boost business growth, supporting a 'Buy' rating at $38 per share. Robinhood Gold membership growth is crucial, with Gold members showing significantly higher assets, deposit growth, and retirement adoption rates, driving transaction-based revenue and net interest income. Robinhood's Q3 outlook is strong, with an anticipated 40% revenue growth for FY24, driven by increased funded customers and average revenue per user, or ARPU.

Supermarket Income REIT is considered a "BUY" due to its quality, undervaluation, and attractive yield of over 7%. The company focuses on UK/France grocery assets, showing solid rent growth, cost reduction, and low leverage. Despite being a small player, the company fulfills all investment criteria and is considered a "SPEC BUY" at best.